1. Market Research
  2. > Cancer Industry

Lymphoma Industry, April 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Hematology Instrument, Nuclear Imaging Equipment, Pap Smear, Cancer Diagnostic, Leukemia, Transplantation, Nuclear Medicine, Blood Disease, Lung Cancer, Infectious Disease, Prostate Cancer, Specialty Hospital.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast -2023-7MM

Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast -2023-7MM

  • $ 4950
  • Industry report
  • April 2017
  • by Delve Insight

DelveInsight’s “Non-Hodgkin Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023-7MM” Reports provides an overview of the disease and global market size of the Non-Hodgkin Lymphoma ...

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) ...

Malignant Mesothelioma - Pipeline Review, H1 2017

Malignant Mesothelioma - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Malignant Mesothelioma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Mesothelioma – Pipeline Review, H1 2017, provides ...

Synovial Sarcoma - Pipeline Review, H1 2017

Synovial Sarcoma - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Synovial Sarcoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma – Pipeline Review, H1 2017, provides an overview ...

Leiomyosarcoma - Pipeline Review, H1 2017

Leiomyosarcoma - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Leiomyosarcoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leiomyosarcoma – Pipeline Review, H1 2017, provides an overview of ...

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epstein–Barr Virus (HHV-4) Infections – ...

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...

Opportunity in Non-Hodgkin Lymphoma Therapeutics in global market - 2017

Opportunity in Non-Hodgkin Lymphoma Therapeutics in global market - 2017

  • $ 4500
  • Industry report
  • March 2017
  • by Feedback Business Consulting

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate - Revenues by players - Top 5 Companies - Market ...

Global Lymphoma Partnering 2010 to 2017

Global Lymphoma Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • March 2017
  • by Currentpartnering

Summary Provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Lymphoma Partnering Terms and ...

Global Non-Hodgkin Lymphoma Partnering 2010 to 2017

Global Non-Hodgkin Lymphoma Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • March 2017
  • by Currentpartnering

Summary Provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Non-Hodgkin Lymphoma ...

About 6100 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Lymphoma Statistics in the UK

  • July 2016
    182 pages
  • Therapy  

    Lymphoma  

    Chemotherapy  

  • United Kingdom  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.